HIV/AIDS
New research on HIV/AIDS from L.X. Liu and co-authors summarized
Published in Vaccine Weekly, March 12th, 2008
"To develop an effective vaccine against the most prevalent HIV strain ''B '/C recombinant'' in China, we compared the immunogenicity of B '/C-derived gp140 and gp145. The codon optimized gp140 and gp145 env gene derived from CN54, an ancestor-like B '/C recombinant strain, were synthesized and cloned into a plasmid as DNA vaccines, designated as pDRVISV140 and pDRVISV145, respectively," researchers in Beijing, People's Republic of China report.
"BALB/c mice were inoculated three times at week 0, 2, and 4 and sacrificed at week 7. Both T cell immunity and humoral immunity were determined. The mock vector pDRVISV1.0 carrying no HIV immunogen was included as control. Our...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-03-12)
More Articles from Vaccine Weekly
- DNA Vaccines
New findings from Y.Z. Yu and co-researchers in the area of DNA vaccines described - DNA Vaccines
Scientists at Centers for Disease Control and Prevention report research in DNA vaccines - Flu Vaccines
Influenza Vaccination Rates Among Health Care Personnel Remain Well Below National Goal - HIV/AIDS
Scientists at Columbia University target HIV/AIDS - Malaria
Studies from University of Massachusetts have provided new information about malaria - Vaccine Safety
Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
